SBI Securities Co., Ltd.
- SEC CIK
- 0001851815
- Latest filing
- Jul 22, 2026
KLRA holding history
Kailera Therapeutics, Inc. in every 13F filed by SBI Securities Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KLRA overviewAll 13F holders of KLRAFull Q2 2026 holdings
- Shares (Q2 2026)
- 1
- Value
- $22
- % of portfolio
- <0.1%
- Quarters held
- 1
- Since Q2 2026